Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016
Background The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis B virus (HBV) infection, existing therapies to control viral replication and prophylaxis to minimise mother-to-child transmissi...
Saved in:
| Main Author: | Mokhbat, Jacques (author) |
|---|---|
| Format: | article |
| Published: |
2018
|
| Online Access: | http://hdl.handle.net/10725/10475 https://doi.org/10.1016/S2468-1253(18)30056-6 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://www.sciencedirect.com/science/article/pii/S2468125318300566 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Occult hepatitis B virus infection in HIV-infected Lebanese patients with isolated antibodies to hepatitis B core antigen
by: Mokhbat, J.
Published: (2008) -
Prevalence of hepatitis C virus isolate genotypes from chronically infected Lebanese patients
by: Mokhbat, J.
Published: (2003) -
Prevalence of hepatitis B and C viruses among migrant workers in Qatar
by: Gheyath K. Nasrallah (9200525)
Published: (2024) -
Treatment as prevention for hepatitis C virus in Pakistan: mathematical modelling projections
by: Houssein H Ayoub (17704359)
Published: (2019) -
Exposure rates to hepatitis C and G virus infections among HIV-infected patients
by: Mokhbat, J.
Published: (2004)